Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells

Molecular Biology of the Cell

Volumn 19, Issue 10, 2008, Pages 4238-4248

  Maubach, Gunter ^a   Lim, Michelle Chin Chia ^a   Zhuo, Lang ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN; ALPHA SMOOTH MUSCLE ACTIN; CATHEPSIN F; COLLAGEN; COLLAGEN TYPE 1; CYSTATIN B; CYSTATIN C; PALMITIC ACID; RETINOL; SMALL INTERFERING RNA;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; DOWN REGULATION; ENZYME ACTIVITY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATHEPSIN F; CATHEPSINS; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEPATOCYTES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSFECTION;

RATTUS;

EID: 57349176440     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-03-0291     Document Type: Article

References (47)

1. Abergel, A., Sapin, V., Dif, N., Chassard, C., Darcha, C., Marcand-Sauvant, J., Gaillard-Martinie, B., Rock, E., Dechelotte, P., and Sauvant, P. (2006). Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig. Dis. Sci. 51, 986-995.
2. Barrett, A. J., and Kirschke, H. (1981). Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol. 80(Pt C), 535-561.
3. Bataller, R., and Brenner, D. A. (2001). Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21, 437-451.
4. Bataller, R., and Brenner, D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209-218.
5. Bestvater, F., Dallner, C., and Spiess, E. (2005). The C-terminal subunit of artificially truncated human cathepsin B mediates its nuclear targeting and contributes to cell viability. BMC Cell Biol. 6, 16
6. Brix, K., Dunkhorst, A., Mayer, K., and Jordans, S. (2008). Cysteine cathepsins: cellular roadmap to different functions. Biochimie. 90, 194-207.
7. Buhling, F., Rocken, C., Brasch, F., Hartig, R., Yasuda, Y., Saftig, P., Bromme, D., and Welte, T. (2004). Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. 164, 2203-2216.
8. Canbay, A., Guicciardi, M. E., Higuchi, H., Feldstein, A., Bronk, S. F., Rydzewski, R., Taniai, M., and Gores, G. J. (2003). Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 112, 152-159.
9. Casciola-Rosen, L. A., Miller, D. K., Anhalt, G. J., and Rosen, A. (1994). Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269, 30757-30760.
10. Dickinson, D. P. (2002). Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit. Rev. Oral Biol. Med. 13, 238-275.
11. Drake, F. H. et al. (1996). Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 271, 12511-12516.
12. Eng, F. J., and Friedman, S. L. (2000). Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J. Physiol. Gastrointest. Liver Physiol. 279, G7-G11.
13. Friedman, S. L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250.
14. Gelb, B. D., Shi, G. P., Chapman, H. A., and Desnick, R. J. (1996). Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238.
15. Goulet, B., Baruch, A., Moon, N. S., Poirier, M., Sansregret, L. L., Erickson, A., Bogyo, M., and Nepveu, A. (2004). A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol. Cell 14, 207-219.
16. Grammatikoff, K., Wu, C., Shi, X., and Fang, F. (2004). SUMO: the proteome's little prince. In: Frontiers of Biotechnology and Pharmaceuticals, Vol. 4, New Brunswick, NJ: Science Press USA, 181-210.
17. Greenwel, P., Rubin, J., Schwartz, M., Hertzberg, E. L., and Rojkind, M. (1993). Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab. Invest. 69, 210-216.
18. Gressner, A. M., Lahme, B., Meurer, S. K., Gressner, O., and Weiskirchen, R. (2006). Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells. World J. Gastroenterol. 12, 731-738.
19. Gressner, A. M., and Weiskirchen, R. (2006). Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cell Mol. Med. 10, 76-99.
20. Gressner, O. A., Weiskirchen, R., and Gressner, A. M. (2007). Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp. Hepatol. 6, 7.
21. Hansen, T., Petrow, P. K., Gaumann, A., Keyszer, G. M., Eysel, P., Eckardt, A., Brauer, R., and Kriegsmann, J. (2000). Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium. J. Rheumatol. 27, 859-865.
22. Jedeszko, C., and Sloane, B. F. (2004). Cysteine cathepsins in human cancer. Biol. Chem. 385, 1017-1027.
23. Kinnman, N., Francoz, C., Barbu, V., Wendum, D., Rey, C., Hultcrantz, R., Poupon, R., and Housset, C. (2003). The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83, 163-173.
24. Lim, M. C., Maubach, G., and Zhuo, L. (2008). Glial fibrillary acidic protein splice variants in hepatic stellate cells - expression and regulation. Mol. Cell 25, 376-384.
25. Linnevers, C., Smeekens, S. P., and Bromme, D. (1997). Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett. 405, 253-259.
26. Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., and Mallat, A. (2005). Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 45, 605-628.
27. Maubach, G., Lim, M. C., Kumar, S., and Zhuo, L. (2007). Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim. Biophys. Acta 1773, 219-231.
28. Mohamed, M. M., and Sloane, B. F. (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775.
29. Monsigny, M., Rondanino, C., Duverger, E., Fajac, I., and Roche, A. C. (2004). Glyco-dependent nuclear import of glycoproteins, glycoplexes and glycosylated plasmids. Biochim. Biophys. Acta 1673, 94-103.
30. Reddy, V. Y., Zhang, Q. Y., and Weiss, S. J. (1995). Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 92, 3849-3853.
31. Riccio, M., Di Giaimo, R., Pianetti, S., Palmieri, P. P., Melli, M., and Santi, S. (2001). Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res. 262, 84-94.
32. Rockey, D. C. (2005). Antifibrotic therapy in chronic liver disease. Clin. Gastroenterol. Hepatol. 3, 95-107.
33. Rozman-Pungercar, J. et al. (2003). Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 10, 881-888.
34. Runger, T. M., Quintanilla-Dieck, M. J., and Bhawan, J. (2007). Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J. Invest. Dermatol. 127, 293-297.
35. Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou-Gharios, G., Jeffery, R., Iredale, J. P., and Forbes, S. J. (2006). The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821.
36. Santamaria, I., Velasco, G., Pendas, A. M., Paz, A., and Lopez-Otin, C. (1999). Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J. Biol. Chem. 274, 13800-13809.
37. Schug, J. (2003). Using TESS to predict transcription factor binding sites in DNA sequence. In: Current Protocols in Bioinformatics, ed. A. D. Baxevanis, J. Wiley and Sons.
38. Shav-Tal, Y., Lee, B., Bar-Haim, S., Vandekerckhove, J., and Zipori, D. (2000). Enhanced proteolysis of pre-mRNA splicing factors in myeloid cells. Exp. Hematol. 28, 1029-1038.
39. Shi, G. P., Bryant, R. A., Riese, R., Verhelst, S., Driessen, C., Li, Z., Bromme, D., Ploegh, H. L., and Chapman, H. A. (2000). Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1186.
40. Sukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A., and Libby, P. (1998). Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102, 576-583.
41. Turk, V., and Bode, W. (1991). The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219.
42. van den Brule, S., Misson, P., Buhling, F., Lison, D., and Huaux, F. (2005). Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respir. Res. 6, 84.
43. Vogel, S., Piantedosi, R., Frank, J., Lalazar, A., Rockey, D. C., Friedman, S. L., and Blaner, W. S. (2000). An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41, 882-893.
44. Wang, B., Shi, G. P., Yao, P. M., Li, Z., Chapman, H. A., and Bromme, D. (1998). Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization. J. Biol. Chem. 273, 32000-32008.
45. Weiskirchen, R., and Gressner, A. M. (2005). Isolation and culture of hepatic stellate cells. Methods Mol. Med. 117, 99-113.
46. Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., and Kaufmann, S. H. (2007). Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26, 117-129.
47. Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., and Kalluri, R. (2007). Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337-23347.